Panion & Bf Biotech (TPE:1760) Total Equity: NT$1,955 Mil (As of Dec. 2025)


TPE:1760 Panion & Bf Biotech Inc TPE:1760
73 GF Score
Price NT$65.90
GF Value NT$96.01
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Panion & Bf Biotech Total Equity?

Panion & Bf Biotech TPE:1760 +4.60% 73 Total Equity is NT$1,955 Mil as of Dec. 2025. GuruFocus rates TPE:1760 with a GF Score™ of 73/100 and a GF Value™ of NT$96.01 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Panion & Bf Biotech's total equity for the quarter that ended in Dec. 2025 was NT$1,955 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Panion & Bf Biotech Total Equity Historical Data

* Premium members only.

The historical data trend for Panion & Bf Biotech's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Panion & Bf Biotech Total Equity Chart

Panion & Bf Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,933.01 2,007.11 1,911.08 1,922.18 1,954.66

Panion & Bf Biotech Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,922.18 1,798.35 1,820.91 1,901.99 1,954.66
TPE:1760
73GF Score
Panion & Bf Biotech Inc TPE:1760
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Panion & Bf Biotech Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Panion & Bf Biotech's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=3226.687-1272.025
=1,955

Panion & Bf Biotech's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=3226.687-1272.025
=1,955

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of NT$1,955 Mil mean?
Panion & Bf Biotech (TPE:1760) has a Total Equity of NT$1,955 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Panion & Bf Biotech and its competitors.
Is Panion & Bf Biotech's Total Equity too high?
Panion & Bf Biotech's current Total Equity is NT$1,955 Mil. Overall, Panion & Bf Biotech has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Panion & Bf Biotech's Total Equity compare to VRTX and REGN?
Panion & Bf Biotech's Total Equity of NT$1,955 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Panion & Bf Biotech and its competitors. Panion & Bf Biotech's current Total Equity is NT$1,955 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Panion & Bf Biotech stock overvalued right now?
Based on GuruFocus' analysis, Panion & Bf Biotech (TPE:1760) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$96.01, compared to a current price of NT$65.90 — trading 31.4% below its estimated fair value. The current Total Equity is NT$1,955 Mil. Panion & Bf Biotech's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Panion & Bf Biotech (TPE:1760), the current Total Equity is NT$1,955 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Panion & Bf Biotech (TPE:1760) Overvalued in 2026?

Based on GuruFocus' analysis, Panion & Bf Biotech stock appears to be undervalued. The current stock price of NT$65.90 is trading 31.4% below its estimated GF Value™ of NT$96.01. GuruFocus considers Panion & Bf Biotech to be Significantly Undervalued.

Key valuation signals for TPE:1760:

  • Total Equity: NT$1,955 Mil
  • GF Value™: NT$96.01 vs. price of NT$65.90 (31.4% below fair value)
  • GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the TPE:1760 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Panion & Bf Biotech Business Description

Address No. 3, Park Street, 16th Floor, Nangang District, Taipei, TWN, 11503
Panion & Bf Biotech Inc operates as a biotech and pharmaceutical company. The company, along with its subsidiaries, is mainly engaged in the manufacture and sales of pharmaceutical, cosmeceutical, diagnostic, medical device, and active pharmaceutical ingredients. It has four core business groups: disease treatment, disease prevention, disease diagnosis, and delayed aging. It has geographic segments in Taiwan; China, Hong Kong, and Macau; the USA; and Korea. It generates a majority of its revenue from the Taiwan segment. Product-wise the firm generates the majority of its revenue from Pharmaceutical products.
73GF Score

Get the complete analysis for TPE:1760

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$65.90
Price
NT$96.01
GF Value